臨床試驗

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

NCT：NCT07216976 · ACTIVE_NOT_RECRUITING

NCT IDNCT07216976

狀態ACTIVE_NOT_RECRUITING

開始日期2025-11-19

SponsorMedtronicNeuro (INDUSTRY)

First posted2025-10-15

Last updated2026-09-10

簡要摘要

The purpose of the study is to evaluate the effectiveness of the Medtronic Adaptive DBS therapy (aDBS) for Parkinson's Disease in China with the Percept family of Implantable Neurostimulators (Percept PC and Percept RC).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。